Michael Polark
Stock Analyst at Wolfe Research
(3.89)
# 1,872
Out of 5,058 analysts
190
Total ratings
50.8%
Success rate
6.4%
Average return
Main Sectors:
Stocks Rated by Michael Polark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Upgraded: Buy | $130 | $104.68 | +24.19% | 6 | Aug 13, 2026 | |
| A Agilent Technologies | Initiated Coverage: Hold | $135 | $175.55 | -23.10% | 1 | Jun 1, 2026 | |
| AVTR Avantor | Rated: Sell | $7 | $16.09 | -56.49% | 1 | Jun 1, 2026 | |
| BRKR Bruker | Downgraded: Hold | n/a | $56.54 | - | 1 | Jun 1, 2026 | |
| CAI Caris Life Sciences | Downgraded: Hold | n/a | $31.76 | - | 1 | Jun 1, 2026 | |
| DHR Danaher | Downgraded: Hold | n/a | $231.50 | - | 1 | Jun 1, 2026 | |
| MTD Mettler-Toledo International | Initiated Coverage: Hold | $1,180 | $1,639.04 | -28.01% | 1 | Jun 1, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $145 | $184.17 | -21.27% | 1 | Jun 1, 2026 | |
| RVTY Revvity | Initiated Coverage: Hold | n/a | $154.71 | - | 1 | Jun 1, 2026 | |
| STVN Stevanato Group | Initiated Coverage: Buy | $21 | $19.25 | +9.09% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $535 | $696.49 | -23.19% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $425 | $444.15 | -4.31% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $375 | $383.02 | -2.09% | 1 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $44.14 | - | 6 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $92 | $88.10 | +4.43% | 8 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $70.12 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $47 | $36.57 | +28.52% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $95.45 | n/a | 6 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $13 | $12.78 | n/a | 11 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $17 | $18.07 | n/a | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $245 → $270 | $224.33 | n/a | 17 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $17.31 | n/a | 1 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $78.50 | n/a | 19 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $350 | $138.77 | n/a | 4 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $28.68 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $180 | $242.23 | n/a | 14 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $405 | $293.23 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $94.38 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $115 | $109.35 | n/a | 19 | Jun 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.5128 | n/a | 17 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $6.45 | n/a | 1 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $140 | $87.71 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $128.22 | n/a | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $16.52 | n/a | 1 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $315 | $427.86 | n/a | 9 | Apr 5, 2022 |
Abbott Laboratories
Aug 13, 2026
Upgraded: Buy
Price Target: $130
Current: $104.68
Upside: +24.19%
Agilent Technologies
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $135
Current: $175.55
Upside: -23.10%
Avantor
Jun 1, 2026
Rated: Sell
Price Target: $7
Current: $16.09
Upside: -56.49%
Bruker
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $56.54
Upside: -
Caris Life Sciences
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $31.76
Upside: -
Danaher
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $231.50
Upside: -
Mettler-Toledo International
Jun 1, 2026
Initiated Coverage: Hold
Price Target: $1,180
Current: $1,639.04
Upside: -28.01%
Repligen
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $145
Current: $184.17
Upside: -21.27%
Revvity
Jun 1, 2026
Initiated Coverage: Hold
Price Target: n/a
Current: $154.71
Upside: -
Stevanato Group
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $19.25
Upside: +9.09%
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $535
Current: $696.49
Upside: -23.19%
Jun 1, 2026
Reiterated: Buy
Price Target: $425
Current: $444.15
Upside: -4.31%
Jun 1, 2026
Rated: Buy
Price Target: $375
Current: $383.02
Upside: -2.09%
May 29, 2026
Downgraded: Hold
Price Target: n/a
Current: $44.14
Upside: -
Apr 1, 2026
Upgraded: Buy
Price Target: $92
Current: $88.10
Upside: +4.43%
Feb 13, 2026
Downgraded: Hold
Price Target: n/a
Current: $70.12
Upside: -
Jan 12, 2026
Initiated Coverage: Buy
Price Target: $47
Current: $36.57
Upside: +28.52%
Aug 25, 2025
Reiterated: Hold
Price Target: n/a
Current: $95.45
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $14 → $13
Current: $12.78
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $19 → $17
Current: $18.07
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $245 → $270
Current: $224.33
Upside: n/a
May 29, 2025
Initiated Coverage: Buy
Price Target: $20
Current: $17.31
Upside: n/a
May 19, 2025
Upgraded: Buy
Price Target: $60
Current: $78.50
Upside: n/a
May 12, 2025
Upgraded: Buy
Price Target: $350
Current: $138.77
Upside: n/a
Mar 31, 2025
Initiated Coverage: Buy
Price Target: $29
Current: $28.68
Upside: n/a
Sep 17, 2024
Downgraded: Sell
Price Target: $180
Current: $242.23
Upside: n/a
Sep 9, 2024
Initiated Coverage: Buy
Price Target: $405
Current: $293.23
Upside: n/a
Sep 9, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $94.38
Upside: n/a
Jun 19, 2024
Upgraded: Buy
Price Target: $115
Current: $109.35
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.5128
Upside: n/a
Oct 19, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $6.45
Upside: n/a
Jul 28, 2023
Reiterated: Buy
Price Target: $121 → $140
Current: $87.71
Upside: n/a
Apr 25, 2023
Downgraded: Hold
Price Target: n/a
Current: $128.22
Upside: n/a
Jan 26, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $16.52
Upside: n/a
Apr 5, 2022
Initiated Coverage: Hold
Price Target: $315
Current: $427.86
Upside: n/a